---
stable_id: R-HSA-9013145
display_name: RAC1 binds effectors at the plasma membrane
species: Homo sapiens
summary: 'In its GTP bound active form, plasma membrane associated RAC1 binds to the
  following cytosolic and plasma membrane effectors:<br>BAIAP2 (Lewis Saravalli et
  al. 2013, Bagci et al. 2020)<br>CAV1 (Nethe et al. 2010, Bagci et al. 2020)<br>CDC42BPA
  (Schwarz et al. 2012)<br>CIT (Madaule et al. 1995)<br>CIT 3 (Di Cunto et al. 1998)<br>CYFIP1
  (Schneck et al. 2003, Bagci et al. 2020)<br>FMNL1 (Yayoshi Yamamoto et al. 2000)<br>IQGAP1
  (Kuroda et al. 1996, Pelikan Conchaudron et al. 2011)<br>IQGAP2 (Brill et al. 1996,
  Ozdemir et al. 2018)<br>IQGAP3 (Wang et al. 2007)<br>KIAA0355 (Bagci et al. 2020:
  interaction studied in detail)<br>NISCH (Reddig et al. 2005)<br>NOX1 complex (Cheng
  et al. 2006, Miyano et al. 2006, Kao et al. 2008)<br>NOX2 complex (Price et al.
  2002)<br>NOX3 complex (Ueyama et al. 2006, Miyano and Sumimoto 2007, Kao et al.
  2008)<br>PAK1 (Parrini et al. 2002)<br>PAK2 (Manser et al. 1994, Manser et al. 1995,
  Bagci et al. 2020)<br>PAK3 (Manser et al. 1995)<br>PAK4 (Abo et al. 1998, Bagci
  et al. 2020)<br>PAK5 (Dan et al. 2002)<br>PAK6 (Lee et al. 2002)<br>PARD6A (Qiu
  et al. 2000)<br>PI3K alpha (Bokoch et at al. 1996, Murga et al. 2002)<br>PKN1 (Owen
  et al. 2003, Modha et al. 2008)<br>PKN2 (Zong et al. 1999)<br>PLD1 (Hammond et al.
  1997)<br>PLD2 (Hiroyama and Exton 2005)<br>WAVE complex (Miki et al. 1998, Suetsugu
  et al. 2006, Bagci et al. 2020)<br><br>The following RAC1 effectors are annotated
  as candidate effectors either because of opposing finding reported in different
  studies or because they have only been reported in the high throughput screen by
  Bagci et al. 2020:<br>ABI1 (Bagci et al. 2020)<br>ABL2 (Bagci et al. 2020)<br>AMIGO2
  (Bagci et al. 2020)<br>ARAP2 (Bagci et al. 2020)<br>BAIAP2L1 (Bagci et al. 2020)<br>BRK1
  (Bagci et al. 2020)<br>CDC42 (Bagci et al. 2020)<br>CDC42EP1 (Bagci et al. 2020:
  binding to activated RAC1; Joberty et al. 1999: no binding to activated RAC1)<br>CDC42EP4
  (Bagci et al. 2020: binding to activated RAC1; Joberty et al. 1999: no binding to
  activated RAC1)<br>DEPDC1B (Bagci et al. 2020)<br>DIAPH3 (Bagci et al. 2020)<br>EPHA2
  (Bagci et al. 2020)<br>ERBIN (Bagci et al. 2020)<br>FERMT2 (Bagci et al. 2020)<br>GIT1
  (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>ITGB1 (Bagci et al. 2020)<br>JAG1
  (Bagci et al. 2020)<br>LAMTOR1 (Bagci et al. 2020)<br>MCAM (Bagci et al. 2020)<br>MPP7
  (Bagci et al. 2020)<br>NCKAP1 (Bagci et al. 2020)<br>NHS (Bagci et al. 2020)<br>PLEKHG3
  (Bagci et al. 2020)<br>PLEKHG4 (Bagci et al. 2020)<br>RAB7A (Bagci et al. 2020)<br>SLC1A5
  (Bagci et al. 2020)<br>SNAP23 (Bagci et al. 2020)<br>SWAP70 (Bagci et al. 2020)<br>TAOK3
  (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3
  (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br>WIP WASP complex (WAS, also
  known as WASP, a component of the WIP WASP complex, was reported to interact with
  active RAC1 by Aspenstrom et al. 1996 and Vastrik et al. 1999, but no interaction
  has been reported between RAC1 and WIP components of the complex, WIPF1, WIPF2 or
  WIPF3) <br><br>Active RAC1 does not bind the following RHO GTPase effectors: <br>ANKLE2
  (Bagci et al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARMCX3 (Bagci et al. 2020)<br>CDC42EP2
  (Joberty et al. 1999)<br>CDC42EP3 (Joberty et al. 1999)<br>CDC42EP5 (Joberty et
  al. 1999)<br>DSG2 (Bagci et al. 2020)<br>DIAPH1 (Higashi et al. 2008)<br>DOCK1 (Bagci
  et al. 2020)<br>DOCK5 (Bagci et al. 2020)<br>ELMO2 (Bagci et al. 2020)<br>FMNL2
  (Block et al. 2012)<br>HSPE1 (Bagci et al. 2020)<br>IL32 (Bagci et al. 2020)<br>LETM1
  (Bagci et al. 2020)<br>LMAN1 (Bagci et al. 2020)<br>NDUFA5 (Bagci et al. 2020)<br>NDUFS3
  (Bagci et al. 2020)<br>PGRMC2 (Bagci et al. 2020)<br>RAPGEF1 (Bagci et al. 2020)<br>ROCK1
  (Leung et al. 1996)<br>ROCK2 (Leung et al. 1996)<br>RTKN (Reid et al. 1996)<br>SHMT2
  (Bagci et al. 2020)<br>SLK (Yamada et al. 2000)<br>SLITRK3 (Bagci et al. 2020)<br>SLITRK5
  (Bagci et al. 2020)<br>STBD1 (Bagci et al. 2020)<br>STX5 (Bagci et al. 2020)<br>VAPB
  (Bagci et al. 2020)'
---

# RAC1 binds effectors at the plasma membrane
**Reactome ID:** [R-HSA-9013145](https://reactome.org/content/detail/R-HSA-9013145)
**Species:** Homo sapiens

## Summary

In its GTP bound active form, plasma membrane associated RAC1 binds to the following cytosolic and plasma membrane effectors:<br>BAIAP2 (Lewis Saravalli et al. 2013, Bagci et al. 2020)<br>CAV1 (Nethe et al. 2010, Bagci et al. 2020)<br>CDC42BPA (Schwarz et al. 2012)<br>CIT (Madaule et al. 1995)<br>CIT 3 (Di Cunto et al. 1998)<br>CYFIP1 (Schneck et al. 2003, Bagci et al. 2020)<br>FMNL1 (Yayoshi Yamamoto et al. 2000)<br>IQGAP1 (Kuroda et al. 1996, Pelikan Conchaudron et al. 2011)<br>IQGAP2 (Brill et al. 1996, Ozdemir et al. 2018)<br>IQGAP3 (Wang et al. 2007)<br>KIAA0355 (Bagci et al. 2020: interaction studied in detail)<br>NISCH (Reddig et al. 2005)<br>NOX1 complex (Cheng et al. 2006, Miyano et al. 2006, Kao et al. 2008)<br>NOX2 complex (Price et al. 2002)<br>NOX3 complex (Ueyama et al. 2006, Miyano and Sumimoto 2007, Kao et al. 2008)<br>PAK1 (Parrini et al. 2002)<br>PAK2 (Manser et al. 1994, Manser et al. 1995, Bagci et al. 2020)<br>PAK3 (Manser et al. 1995)<br>PAK4 (Abo et al. 1998, Bagci et al. 2020)<br>PAK5 (Dan et al. 2002)<br>PAK6 (Lee et al. 2002)<br>PARD6A (Qiu et al. 2000)<br>PI3K alpha (Bokoch et at al. 1996, Murga et al. 2002)<br>PKN1 (Owen et al. 2003, Modha et al. 2008)<br>PKN2 (Zong et al. 1999)<br>PLD1 (Hammond et al. 1997)<br>PLD2 (Hiroyama and Exton 2005)<br>WAVE complex (Miki et al. 1998, Suetsugu et al. 2006, Bagci et al. 2020)<br><br>The following RAC1 effectors are annotated as candidate effectors either because of opposing finding reported in different studies or because they have only been reported in the high throughput screen by Bagci et al. 2020:<br>ABI1 (Bagci et al. 2020)<br>ABL2 (Bagci et al. 2020)<br>AMIGO2 (Bagci et al. 2020)<br>ARAP2 (Bagci et al. 2020)<br>BAIAP2L1 (Bagci et al. 2020)<br>BRK1 (Bagci et al. 2020)<br>CDC42 (Bagci et al. 2020)<br>CDC42EP1 (Bagci et al. 2020: binding to activated RAC1; Joberty et al. 1999: no binding to activated RAC1)<br>CDC42EP4 (Bagci et al. 2020: binding to activated RAC1; Joberty et al. 1999: no binding to activated RAC1)<br>DEPDC1B (Bagci et al. 2020)<br>DIAPH3 (Bagci et al. 2020)<br>EPHA2 (Bagci et al. 2020)<br>ERBIN (Bagci et al. 2020)<br>FERMT2 (Bagci et al. 2020)<br>GIT1 (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>ITGB1 (Bagci et al. 2020)<br>JAG1 (Bagci et al. 2020)<br>LAMTOR1 (Bagci et al. 2020)<br>MCAM (Bagci et al. 2020)<br>MPP7 (Bagci et al. 2020)<br>NCKAP1 (Bagci et al. 2020)<br>NHS (Bagci et al. 2020)<br>PLEKHG3 (Bagci et al. 2020)<br>PLEKHG4 (Bagci et al. 2020)<br>RAB7A (Bagci et al. 2020)<br>SLC1A5 (Bagci et al. 2020)<br>SNAP23 (Bagci et al. 2020)<br>SWAP70 (Bagci et al. 2020)<br>TAOK3 (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3 (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br>WIP WASP complex (WAS, also known as WASP, a component of the WIP WASP complex, was reported to interact with active RAC1 by Aspenstrom et al. 1996 and Vastrik et al. 1999, but no interaction has been reported between RAC1 and WIP components of the complex, WIPF1, WIPF2 or WIPF3) <br><br>Active RAC1 does not bind the following RHO GTPase effectors: <br>ANKLE2 (Bagci et al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARMCX3 (Bagci et al. 2020)<br>CDC42EP2 (Joberty et al. 1999)<br>CDC42EP3 (Joberty et al. 1999)<br>CDC42EP5 (Joberty et al. 1999)<br>DSG2 (Bagci et al. 2020)<br>DIAPH1 (Higashi et al. 2008)<br>DOCK1 (Bagci et al. 2020)<br>DOCK5 (Bagci et al. 2020)<br>ELMO2 (Bagci et al. 2020)<br>FMNL2 (Block et al. 2012)<br>HSPE1 (Bagci et al. 2020)<br>IL32 (Bagci et al. 2020)<br>LETM1 (Bagci et al. 2020)<br>LMAN1 (Bagci et al. 2020)<br>NDUFA5 (Bagci et al. 2020)<br>NDUFS3 (Bagci et al. 2020)<br>PGRMC2 (Bagci et al. 2020)<br>RAPGEF1 (Bagci et al. 2020)<br>ROCK1 (Leung et al. 1996)<br>ROCK2 (Leung et al. 1996)<br>RTKN (Reid et al. 1996)<br>SHMT2 (Bagci et al. 2020)<br>SLK (Yamada et al. 2000)<br>SLITRK3 (Bagci et al. 2020)<br>SLITRK5 (Bagci et al. 2020)<br>STBD1 (Bagci et al. 2020)<br>STX5 (Bagci et al. 2020)<br>VAPB (Bagci et al. 2020)
